(Q36967585)

17 August 2017

1 reference

title

Nitric oxide deficiency in chronic kidney disease (English)

1 reference

17 August 2017

Chris Baylis

1

1 reference

17 August 2017

10 October 2007

1 reference

American Journal of Physiology - Renal Physiology

17 August 2017

1 reference

17 August 2017

294

1 reference

17 August 2017

1

1 reference

17 August 2017

F1-9

1 reference

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

17 August 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Nitric oxide synthases: structure, function and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L‐arginine in regenerated endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Premature cardiovascular disease in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Arginine: biochemistry, physiology, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Peroxisome Proliferator-Activated Receptor γ Agonist Provides Superior Renal Protection versus Angiotensin-Converting Enzyme Inhibition in a Rat Model of Type 2 Diabetes with Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Relationship of asymmetric dimethylarginine to haemodialysis hypotension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Protein methylation in animal cells. I. Purification and properties of S-adenosyl-L-methionine:protein (arginine) N-methyltransferase from Krebs II ascites cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Protein methylation in animal cells. II. Inhibition of S-adenosyl-L-methionine:protein(arginine) N-methyltransferase by analogs of S-adenosyl-L-homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Acute administration of L-arginine does not improve arterial endothelial function in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Arginase inhibition reduces endothelial dysfunction and blood pressure rising in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Resistance to renal damage by chronic nitric oxide synthase inhibition in the Wistar-Furth rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Ischemic preconditioning-mediated restoration of membrane dystrophin during reperfusion correlates with protection against contraction-induced myocardial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

DOCA/NaCl-induced chronic kidney disease: a comparison of renal nitric oxide production in resistant and susceptible rat strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Sexual dimorphism in the aging kidney: Effects on injury and nitric oxide system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Protection of Wistar Furth Rats from Chronic Renal Disease Is Associated with Maintained Renal Nitric Oxide Synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

The nitric oxide pathway modulates hemangioblast activity of adult hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Protective effects of demethylbellidifolin on myocardial ischemia-reperfusion injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Effects of supplemental oxygen administration on coronary blood flow in patients undergoing cardiac catheterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Common genetic variation in a basal promoter element alters DDAH2 expression in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Recent advances in protein methylation: enzymatic methylation of nucleic acid binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Cloning and sequencing of cDNA encoding NG,NG-dimethylarginine dimethylaminohydrolase from rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Detection of NG,NG-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Arginine, citrulline, and nitric oxide metabolism in end-stage renal disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

S-Adenosylmethionine:protein-arginine methyltransferase. Purification and mechanism of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Disruption of methylarginine metabolism impairs vascular homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Biological significance of endogenous methylarginines that inhibit nitric oxide synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

In vivo and in vitro arginine methylation of RNA-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Effects of guanidino and uremic compounds on nitric oxide pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Recent advances in arginine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Gut and liver handling of asymmetric and symmetric dimethylarginine in the rat under basal conditions and during endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Metabolism of NG,NG-and NG,N'G-dimethylarginine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Effect of Shear Stress on Asymmetric Dimethylarginine Release From Vascular Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Glycoxidation and inflammation in renal failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

From rats to man: a perspective on dietary L-arginine supplementation in human renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Arginase inhibition slows the progression of renal failure in rats with renal ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Indices of activity of the nitric oxide system in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Total nitric oxide production is low in patients with chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Intracellular calcium-release channels: regulators of cell life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Arginine uptake is attenuated through modulation of cationic amino-acid transporter-1, in uremic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Dimethylarginine dimethylaminohydrolase activity modulates ADMA levels, VEGF expression, and cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Renal neuronal nitric oxide synthase protein expression as a marker of renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Abnormalities of endothelial function in patients with predialysis renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Asymmetric dimethylarginine and kidney disease--marker or mediator?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Urea transporters are distributed in endothelial cells and mediate inhibition of L-arginine transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Reduced nitric oxide synthase activity in rats with chronic renal disease due to glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Dimethylarginines in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Plasma from ESRD patients inhibits nitric oxide synthase activity in cultured human and bovine endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Chronic nitric oxide inhibition model six years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Renal and systemic nitric oxide synthesis in rats with renal mass reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Nitric Oxide Production Is Reduced in Patients With Chronic Renal Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00424.2007

10.1152/AJPRENAL.00424.2007

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17928410